Delivery Order SPE2DB20D3101-SPE2DB22FJ6Q0
Award Date
4/29/22
Potential Completion Date
5/2/22
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $4,395.13 Firm Fixed Price delivery order is for the supply of 60 units of the prescription drug Valganciclovir 450 mg tablets. The contract has an ultimate completion date of February 8, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,507.63, is for the delivery of 60 tablets of the medication Valganciclovir 450 mg. The contract has a firm fixed price and an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,605.14, is for the delivery of 60 count valganciclovir 450 mg tablets. It is a firm-fixed price delivery order with a completion date of December 5, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Valganciclovir 450 mg tablets. The fixed-price contract has a ceiling value of $1,559.32 and a completion date of February 9, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award, valued at $8,191.37, is for the delivery of valganciclovir hydrochloride, a pharmaceutical product used in the treatment of certain medical conditions. The contract has a period of performance through May 7, 2024, and is a firm fixed-price delivery order with no set-aside designation, indicating full and open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,147.05 firm fixed-price delivery order is for the supply of 60 tablets of 450 mg Valganciclovir, a medication used to treat cytomegalovirus infections. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $1,668.46 and is for the delivery of valganciclovir 450 mg tablets. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is November 15, 2023. This award is not designated as a set-aside contract. AmerisourceBergen...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,376.42 firm fixed-price delivery order is for the supply of 88 ml vials of 50 mg/ml valganciclovir HCl, a medication used in the treatment of viral infections. The contract has an ultimate completion date of March 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a delivery order for $2,356.52 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The order is for valganciclovir hydrochloride 50 mg/mL oral solution, with an ultimate completion date of August 21, 2024. The contract is a firm-fixed price type with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities and...
This is a $2,458.82 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567117522 valganciclovir HCL 50 mg/ml 88ml, a specialty medication. The award date is January 31, 2025, with a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...